Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Cogent Biosciences, Inc. Financials Banner

Cogent Biosciences, Inc. Financials

COGT Stock Analysis

Page title

Section title

COGT Income Statement Key Metrics

  • Revenue(TTM)5.59 M
  • Gross Profit(TTM)1.79 M
  • EBITDA(TTM)-241.66 M
  • Net Income(TTM)-227.05 M
  • EPS Diluted(TTM)-2.48

Decode COGT's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

COGT earnings and revenue history

COGT Return on Equity

See how efficiently COGT generates profit for it's shareholders.

-74.63%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of COGT (-0.746) is higher than the average of its peers (-0.767).

Return on Equity Growth

COGT's Return on Equity has grown significantly over the past 10 years, increasing by over 25.76%.

COGT Revenue Growth

See how COGT has grown it's revenue over the past 10 years.


Revenue Growth

COGT's revenue has shown poor growth over the past 10 years, increasing by only -100%.

COGT FY, 2023 Revenue Breakdown

See how COGT converts it's revenue into profit.

COGT Balance Sheet Health

COGT Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

COGT financial position analysis

Short Term Liabilities

COGT's short term assets($271M) can safely cover it's short term liabilities($38M).

Long Term Liabilities

COGT's short term assets($271M) can safely cover it's long term liabilities($17M).

COGT Debt to Equity